About ASCPT
Advancing the science and practice of clinical pharmacology for the therapeutic benefit of patients and society.
The American Society for Clinical Pharmacology and Therapeutics (ASCPT) was founded in 1900, and consists of over 2,100 professionals committed to promoting and advancing the science and practice of human pharmacology and therapeutics for the benefit of patients and society. The Society is the largest scientific and professional organization serving the discipline of clinical pharmacology.
ASCPT focuses on improving the understanding and use of existing drug therapies and developing safer and more effective treatments for the future. Our memberships' unique combination of scientific and clinical expertise makes them especially qualified to understand the impact of disease on patients, the compelling need for effective drug therapy and the efforts necessary to meet those needs. Such efforts include research, exchange of scientific information, and awareness of legislative requirements that affect drug development and regulation.
Vision Statement
ASCPT's leadership and far reaching influence have made it the authority on and preferred forum for the science and practice of clinical pharmacology and therapeutics.
Strategic Plan
The Society's strategic plan for 2010 through 2015 focuses on five goals of leadership, influence, outreach, science and education. Read more about ASCPT's goals and objectives in the strategic plan.
Core Principles
- The strength of ASCPT lies in its multidisciplinary nature.
- The continuum of clinical pharmacology strengthens the discovery, development, regulation, and safe and effective utilization of medications.
- Clinical pharmacology optimizes the use of therapeutics to ensure quality patient care.
- It is important that healthcare professionals and biomedical scientists involved in human pharmacology receive training on the principles of clinical pharmacology.
Contact Us >>
|